Equillium Inc (EQ) Stock News

A class action lawsuit has been filed against EquipmentShare.Com Inc on behalf of investors who purchased stock during its IPO in January 2026 or through June 2026. The lawsuit was triggered by a June 24, 2026 report alleging undisclosed related party transactions that netted EquipmentShare founders at least $77 million. Following the report, the company's stock price fell 6.62% on June 24 and declined an additional 11.7% the next trading day.

Rosen Law Firm is urging investors who purchased EquipmentShare.com Inc securities during its January 2026 IPO or between January 23 and June 23, 2026 to join a securities class action lawsuit. The lawsuit alleges that EquipmentShare made materially false statements and failed to disclose undisclosed related party transactions with entities owned by co-founders, resulting in misleading financial statements. The lead plaintiff deadline is September 21, 2026.

Law firm Lowey Dannenberg is investigating EquipmentShare.com Inc. (NASDAQ: EQPT) for potential federal securities law violations following a short report alleging undisclosed related-party transactions worth at least $77 million to company founders. The investigation concerns whether the company provided accurate and complete information to investors. EquipmentShare's stock fell from $24.50 at IPO in January 2026 to $19.69 following the allegations in June 2026.

Law firm Lowey Dannenberg is investigating EquipmentShare.com Inc. (NASDAQ: EQPT) for potential federal securities violations following a short report alleging undisclosed related-party transactions worth at least $77 million to company founders. The stock fell from $24.50 at IPO in January 2026 to $19.69 after the allegations were published in June 2026.

Grabar Law Office has initiated multiple shareholder investigations into alleged securities fraud and fiduciary duty breaches at EquipmentShare.com, Insulet Corporation, New Era Energy & Digital, and Planet Fitness. The investigations allege undisclosed related-party transactions, defective manufacturing controls, misleading statements about business progress, and false marketing claims that caused shareholders to purchase securities at artificially inflated prices.

A class action lawsuit has been filed against EquipmentShare.Com Inc (NASDAQ: EQPT) on behalf of investors who purchased stock during its IPO on January 23, 2026 through June 23, 2026. The lawsuit was triggered by a June 24, 2026 report alleging undisclosed related party transactions netting founders at least $77 million, causing the stock to decline 6.62% that day and an additional 11.7% the following day. The lead plaintiff deadline is September 21, 2026.

Robbins LLP is reminding investors of the lead plaintiff deadline in a class action lawsuit against EquipmentShare.com, Inc. (EQPT). The lawsuit alleges the company made false and misleading statements regarding undisclosed related party transactions worth at least $77 million involving entities affiliated with company founders. Following a critical report by Umibōzu Research on June 24, 2026, EQPT stock declined over 34.5% from its IPO price of $24.50 to lows of $16.06.

Grabar Law Office has initiated investigations on behalf of shareholders of four NASDAQ-listed companies: Cogent Communications (CCOI), EquipmentShare (EQPT), Photronics (PLAB), and PROCEPT BioRobotics (PRCT). The investigations allege breaches of fiduciary duties, including misrepresentation of business fundamentals, undisclosed related-party transactions, false demand statements, and artificially inflated sales figures. Shareholders who purchased shares before specified dates and still hold them may seek corporate reforms and damages at no cost.

A class action lawsuit has been filed against EquipmentShare.com, Inc. (EQPT) alleging the company made false and misleading statements regarding undisclosed related-party transactions in its January 2026 IPO. An Umibōzu Research report revealed that entities affiliated with company founders received at least $77 million through undisclosed transactions, causing the stock to fall over 6% on June 24, 2026. Investors with substantial losses can seek appointment as lead plaintiff by September 21, 2026.

Rosen Law Firm has filed a class action lawsuit against EquipmentShare.com Inc (NASDAQ: EQPT) on behalf of investors who purchased securities during the IPO in January 2026 and through June 23, 2026. The lawsuit alleges that defendants made materially false and misleading statements and failed to disclose undisclosed related party transactions, misleading financial statements, and material adverse facts about the company's business and operations. The deadline to serve as lead plaintiff is September 21, 2026.

EquipmentShare.com Inc. (EQPT) faces a securities fraud lawsuit after allegedly making false statements about terminating related-party transactions with founder-controlled entities. A short-seller report revealed undisclosed transactions netting founders at least $77 million, causing the stock to plummet 34.5% below its IPO price. Investors who purchased shares between January 23 and June 23, 2026, may be eligible to recover losses.

The Rosen Law Firm has announced an investigation into potential securities claims against EquipmentShare.com Inc. following a June 2025 report by Umibōzu Research alleging the company engaged in self-dealing and misrepresented itself as a tech-powered disruptor. The report claimed EquipmentShare's leadership used obfuscation to extract value at shareholder expense. The stock fell 11.7% following the report's publication. The firm is preparing a class action lawsuit to recover investor losses.

Pomerantz LLP is investigating EquipmentShare.com Inc. for potential securities fraud following a short report by Umibōzu Research alleging undisclosed related-party transactions worth at least $77 million involving company founders. The allegations triggered a 17.55% stock price decline on June 25, 2026, just months after the company's January 2026 IPO at $24.50 per share.

A securities class action lawsuit has been filed against Insulet Corporation alleging the company made false and misleading statements about its manufacturing controls and procedures. The lawsuit covers investors who purchased Insulet securities between February 21, 2025 and May 26, 2026. Two voluntary medical device corrections were disclosed in March and May 2026 involving manufacturing issues with Omnipod products, resulting in significant stock price declines. The deadline to seek lead plaintiff status is August 31, 2026.

Flexible Solutions International (FSI) announced it has traded its remaining 19.9% stake in FL LLC to recover exclusive rights to manufacture and sell four agricultural products across Latin America, Central America, the Caribbean, and South America. The move follows an acquirer's failure to meet payment obligations on a previous 30.1% equity sale. CEO Dan O'Brien expects significant revenue recovery in the second half of 2026.

Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to proposed mergers and acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be prioritized over ordinary shareholder interests.

Activist shareholder Howard Todd Horberg, holding 5.61% of Equus Total Return, Inc. (NYSE: EQS), has filed a Schedule 13D challenging the board's stewardship. The filing highlights five consecutive years of net investment losses, no dividends since 2009, a 65% decline in net asset value over two years, and executive compensation of $1.87 million while the company faces going-concern warnings. Horberg calls for suspension of automatic salary escalators, an independent compensation review, and a strategic review including potential merger or acquisition to address the company's concentrated portfolio and excessive overhead.

A federal securities class action has been filed against BitGo Holdings, Inc. alleging that the company and its executives made false and misleading statements by understating risks posed by declining digital asset prices to its business. The lawsuit covers investors who purchased BTGO securities during the January 22, 2026 IPO through May 13, 2026. The deadline to seek lead plaintiff appointment is August 7, 2026.

A federal securities class action has been filed against Badger Meter, Inc. (NASDAQ: BMI) alleging that the company and its executives made false and misleading statements about strong demand and growth prospects while concealing unsustainable financial results. The lawsuit covers investors who purchased BMI stock between April 18, 2024 and April 16, 2026. The deadline to seek lead plaintiff appointment is August 3, 2026.

Faruqi & Faruqi, LLP is investigating a federal securities class action against AeroVironment, Inc. (NASDAQ: AVAV) for allegedly making false and misleading statements about its business prospects. The lawsuit covers investors who purchased AVAV stock between June 25, 2025 and March 10, 2026. The complaint alleges the company understated competition for its SCAR program contracts and overstated financial prospects. The deadline to seek lead plaintiff appointment is July 27, 2026.

Faruqi & Faruqi, LLP is investigating securities fraud claims against Roblox Corporation, alleging the company made false and misleading statements about its organic growth potential while concealing the negative impact of its age verification rollout. The lawsuit covers investors who purchased RBLX securities between October 30, 2025 and April 30, 2026. On April 30, 2026, Roblox announced disappointing Q1 results with slashed bookings guidance (8-12%) and revealed age verification adoption impacts were far greater than previously disclosed, causing the stock to plummet 18.33% in a single day from $55.26 to $45.13 per share. The deadline to seek lead plaintiff appointment is August 7, 2026.

Faruqi & Faruqi, LLP is investigating securities fraud claims against Calix, Inc., alleging the company made false statements about Q1 2026 margins by concealing that strong results were artificially inflated by advanced memory component purchasing. When the company disclosed on April 21, 2026 that its advanced supply had depleted and it would face rising market prices, CALX stock fell 13.98%. The deadline to seek lead plaintiff status is July 27, 2026.

A securities class action lawsuit has been filed against Globant S.A. for allegedly making false and misleading statements about its Latin American operations. The company disclosed significant failures on August 14, 2025, announcing a 2% headcount reduction (1,000 employees) and a $47.6 million restructuring charge, causing the stock to drop from $78.12 to $66.46 per share in a single day. Investors who purchased GLOB stock between February 15, 2024 and August 14, 2025 may be eligible to participate in the class action, with a June 23, 2026 deadline to seek lead plaintiff appointment.

A federal securities class action has been filed against Regencell Bioscience Holdings Limited (NASDAQ: RGC) alleging that the company and its executives made false and misleading statements by concealing vulnerability to market manipulation and regulatory risks. The DOJ launched an investigation into trading in RGC's ordinary shares, disclosed on October 31, 2025, causing the stock to fall 18.56%. Investors who purchased RGC securities between October 28, 2024 and October 31, 2025 may be eligible to participate in the lawsuit, with a June 23, 2026 deadline to seek lead plaintiff appointment.

Faruqi & Faruqi, LLP is investigating securities fraud claims against Lucid Group, reminding investors of the July 28, 2026 deadline to seek lead plaintiff status. The lawsuit alleges that Lucid and its executives made false statements about manufacturing capabilities while concealing a supplier quality issue that disrupted Lucid Gravity deliveries. The disclosure of only 3,093 Q1 vehicles delivered, $280-284M revenue (vs. $433.8M consensus), and over $1B net loss caused significant stock price declines.

The S&P 500 closed higher by 26 basis points, but market tensions are rising as the VIXEQ-to-VIX spread hits a record 30.8, indicating elevated single-stock volatility relative to overall market volatility. This dispersion is driven by rising implied volatility in semiconductor stocks, particularly Micron, Broadcom, and IBM. Historically, such spreads have preceded significant market pullbacks. Bitcoin fell 3% and broke below a key uptrend, suggesting potential further weakness ahead.

Diluted EPS Q2 Adjusted 1 $2.03 (10%) q/q, (12%) y/y Return on equity Q2 Adjusted 1 10.2% (90 bps) q/q, (170 bps) y/y PPPT 2 Q2 Adjusted 1 $153.1MM (2%) q/q, (4%) y/y Total PCL Q2 Adjusted 1 $45.4MM +16% q/q, +50% y/y CET1 ratio 13.6% Total capital ratio 17.1% Q2 Reported $1.29 (39%) q/q, (42%) y/y Q2 Reported 6.5% (390 bps) q/q, (490 bps) y/y Q2 Reported $119.5 (19%) q/q, (23%) y/y Q2 Reported $45.4MM +16% q/q, +50% y/y Common share dividend declared $0.61/share +3% q/q, 15% y/y TORONTO , May 27, 2026 /CNW/ - EQB Inc. (TSX: EQB ) today reported earnings for the second quarter and six months ended April 30, 2026. Adjusted diluted EPS 1 : $2.03, (10%) q/q and (12%) y/y (reported $1.29) Adjusted net income 1 : $78.3 million, (8%) q/q and (17%) y/y (reported $51.3 million) Adjusted PPPT 1,2 : $153.1 million, (2%) q/q and (4%) y/y (reported $119.5 million) Adjusted ROE 1 : 10.2%, (90 bps) q/q and (170 bps) y/y (reported 6.5%) Revenue : $302.4 million, (1%) q/q and (4%) y/y (reported $302.4 million) Book value per share : $81.46, flat q/q and +1% y/y EQ Bank customers : 659,000, +4% q/q and +18% y/y Common share dividends declared : $0.61 per share, +3% q/q and +15% y/y Capital: CET1 ratio of 13.6% and total capital ratio of 17.1% "The second quarter reflected solid performance during a persistently uncertain economic environment and our team performed well against this backdrop, continuing to demonstrate operating discipline, renewed focus, and financial resilience," said Chadwick Westlake, President and CEO. "As we look ahead to the second half of the year, our business will meaningfully shift with the anticipated July 1 close of our PC Financial transaction – positioning us to serve millions of Canadians as a challenger at scale. Through a new loyalty-linked banking ecosystem, we will provide Canadians with better value, better products, more rewards and new channels, p

Olema Oncology announced a clinical trial collaboration with Bayer to evaluate OP-3136, a KAT6 inhibitor, in combination with darolutamide in approximately 36 patients with metastatic castration-resistant prostate cancer. The Phase 1b/2 study is expected to initiate in H2 2026 and represents the first clinical collaboration for OP-3136. Olema will lead the study while maintaining full global commercial rights to OP-3136, with clinical data and inventions jointly owned.

Flyte, a regional air mobility company, announced full-scale activation of its Memorial Day flight network across the Northeast corridor, deploying aircraft on high-frequency short-haul routes including NYC to Nantucket, Hamptons, and Martha's Vineyard. The company aims to capture premium travel demand during the holiday weekend surge by offering sub-one-hour flights as an alternative to congested ground travel.